These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1335951)

  • 21. [Antithrombotic effects of molsidomine, isosorbide dinitrate and verapamil in a laser-induced thrombosis model].
    Krupiński K; Breddin H; Bielawiec M
    Kardiol Pol; 1993 Aug; 39(8):100-4. PubMed ID: 8231003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Some effects of prophylactic aspirins and heparins on concurrent arterial and venous thrombosis in the same animal.
    Iomhair MM; Lavelle SM
    Thromb Res; 1998 Dec; 92(5):229-32. PubMed ID: 9851814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effects of ticlopidine and aspirin, administered alone and in combination, on thrombus formation in rat cerebral vessels.
    Sasaki Y; Ishii I; Giddings JC; Yamamoto J
    Haemostasis; 1996; 26(3):150-6. PubMed ID: 8738589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The venous antithrombotic effect of LF 1351 in the rat following oral administration.
    Millet J; Theveniaux J; Brown NL
    Thromb Haemost; 1992 Jan; 67(1):176-9. PubMed ID: 1615473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental studies on the antithrombotic and haemorrhagic effects of heparin and a low molecular weight heparin derivative.
    Kaiser B; Hauptmann J; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):119-25. PubMed ID: 2459005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antithrombotic effect of argatroban on the pial vessels of the rat: a study with He-Ne laser-induced thrombus formation.
    Sasaki Y; Morii S; Yamashita T; Yamamoto J
    Haemostasis; 1993; 23(2):104-11. PubMed ID: 8365687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of thromboxane receptor antagonists on venous thrombosis in rats.
    Schumacher WA; Heran CL
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1109-15. PubMed ID: 2522985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of low-molecular-weight heparins on laser-induced thrombus formation in rat mesenteric vessels.
    Weichert W; Breddin HK
    Haemostasis; 1988; 18 Suppl 3():55-63. PubMed ID: 2840375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation on antithrombotic effect of aspirin eugenol ester from the view of platelet aggregation, hemorheology, TXB2/6-keto-PGF1α and blood biochemistry in rat model.
    Ma N; Liu XW; Yang YJ; Shen DS; Zhao XL; Mohamed I; Kong XJ; Li JY
    BMC Vet Res; 2016 Jun; 12(1):108. PubMed ID: 27296110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new thromboxane receptor antagonist, Z-335, ameliorates experimental thrombosis without prolonging the rat tail bleeding time.
    Tanaka T; Ito S; Higashino R; Fukuta Y; Fukuda Y; Takei M; Kurimoto T; Tamaki H
    Thromb Res; 1998 Sep; 91(5):229-35. PubMed ID: 9755835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the biological effects of low-molecular-weight heparins.
    Bender N; Seidl C; Weichert W; Breddin HK
    Haemostasis; 1988; 18 Suppl 3():23-32. PubMed ID: 2840371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antithrombotic effects of aspirin and LMWH in a laser-induced model of arterials and venous thrombosis.
    Imbault P; Doutremepuich F; Aguejouf O; Doutremepuich C
    Thromb Res; 1996 Jun; 82(6):469-78. PubMed ID: 8794519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
    Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW
    Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithrombotic effect of recombinant truncated tissue factor pathway inhibitor (TFPI1-161) in experimental venous thrombosis--a comparison with low molecular weight heparin.
    Holst J; Lindblad B; Bergqvist D; Nordfang O; Ostergaard PB; Petersen JG; Nielsen G; Hedner U
    Thromb Haemost; 1994 Feb; 71(2):214-9. PubMed ID: 8191401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antithrombotic efficacy in a rat model of the low molecular weight heparin, reviparin sodium, administered by the oral route.
    Hiebert LM; Wice SM; Ping T; Herr D; Laux V
    Thromb Haemost; 2001 Jan; 85(1):114-8. PubMed ID: 11204561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
    Salvati P; Dho L; Ukmar G; Vaga L; Rimoldi O; Patrono C
    J Pharmacol Exp Ther; 1994 Apr; 269(1):238-45. PubMed ID: 8169831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo pharmacological characterization of BM-613 [N-n-pentyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea], a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist.
    Hanson J; Rolin S; Reynaud D; Qiao N; Kelley LP; Reid HM; Valentin F; Tippins J; Kinsella BT; Masereel B; Pace-Asciak C; Pirotte B; Dogné JM
    J Pharmacol Exp Ther; 2005 Apr; 313(1):293-301. PubMed ID: 15626721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antithrombotic activity of F 16618, a new PAR1 antagonist evaluated in extracorporeal arterio-venous shunt in the rat.
    Létienne R; Leparq-Panissié A; Calmettes Y; Nadal-Wollbold F; Perez M; Le Grand B
    Biochem Pharmacol; 2010 Jun; 79(11):1616-21. PubMed ID: 20188709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ASP6537, a novel highly selective cyclooxygenase-1 inhibitor, exerts potent antithrombotic effect without "aspirin dilemma".
    Sakata C; Kawasaki T; Kato Y; Abe M; Suzuki K; Ohmiya M; Funatsu T; Morita Y; Okada M
    Thromb Res; 2013 Jul; 132(1):56-62. PubMed ID: 23522855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new low molecular weight heparan sulphate antagonizes kappa-carrageenan-induced thrombosis in rats.
    Gervasi GB; Bartoli C; Carpita G
    Pharmacol Res; 1991 Jul; 24(1):59-63. PubMed ID: 1658763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.